Welcome : Guest

Fulford (India) Ltd. (India) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Fulford (India) Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 33 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-35045
Price: $1650
Company Type: Public
Pages: 35
Date: March 2016
Market Data Tables: 33

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Fulford, India Ltd.’s (Operations) Sales by Product Segment (2014-2015) in Percentage for Creams and Ointments, Injectables, Tablets, Capsules and Liquids......3
Dermatology Drugs......4
Table 2: Anti-acne Topical Dermatology Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Acne, AK + Psoriasis + Dermatitis + Others, Anti-Fungal Combo, Anti-Infective, Coagulants, Corticosteroids Combo, and Corticosteroids Plain......4
Table 3: Dermatology Biologics Market by Product Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......5
Table 4: Bone Disease Drugs Market by Therapy Worldwide (2014) - Percentage Share Breakdown by Value Sales for Bisphosphonates, Bone Oncology, Hormonal Agents, SERMS, and Others......6
Table 5: Dermatology Drugs Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......7
Table 6: Dermatology Market by Category in the US (2015) - Percentage Share Breakdown by Value for Genericised, Off-Patent but No Generics, On-Patent, and Others......8
Therapeutic Drugs......9
Table 7: Therapeutic Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......9
Hepatitis Drugs......10
Table 8: Hepatitis C Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno Modulator, Polymerase Inhibitor, Protease Inhibitors, and Others (Includes Ribavirin)......10
Table 9: Hepatitis C Market by Genotype Worldwide (2015) - Percentage Share Breakdown by Value for Genotype 1, Genotype 2 and Others......11
Immunology......12
Table 10: Immunology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Dermatology, Gastroenterology, and Rheumatology......12
Oncology Drugs......13
Table 11: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......13
Table 12: Oncology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Dialysis Catheters, Enteral Feeding, Peripherally Inserted Central Catheters, Ports, Ultrasound, and Others......14
Table 13: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......15
Table 14: Hereditary Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......16
Table 15: Oncology/Hematology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......17
Table 16: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......18
Table 17: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......19
Oncology Genomics......20
Table 18: Oncology Genomics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......20
Table 19: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......21
Table 20: Oncology Genomics Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......22
Dermatology Drugs......23
Table 21: Market Shares of Leading Dermatological Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......23
Table 22: Market Shares of Leading Dermatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Biogen Idec, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, and Others......24
Table 23: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......25
Hepatitis Drugs......26
Table 24: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......26
Table 25: Market Shares of Leading Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Co (BMY), GlaxoSmithKline Plc (GSK), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Vertex Pharmaceuticals, Inc. (VRTX), and Others......27
Table 26: Market Shares of Leading Hepatitis B Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co., Ltd., Ningbo Boya Medical Equipment Co., Ltd., Shuyang Group, Tonrol Biopharm Co., Ltd., and Others......28
Table 27: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......29
Table 28: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......30
Table 29: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......31
Table 30: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......32
Oncology Drugs......33
Table 31: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......33
Table 32: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......34
Table 33: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......35